Acacia Research Corp. Subsidiary Acquires Patent on Stent Graft Technology

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Acacia Research Corp (Nasdaq:ACTG) announced today that a subsidiary has acquired a patent for stent graft technology. “Acacia continues to increase the number of patent portfolios we control in the medical device and diagnostics sectors,” commented Paul Ryan, CEO. “Acacia is expanding its presence as a leader in patent licensing for both the technology and medical technology sectors.”